Trial Profile
A 52-Week Randomized, Double-Blind, Multicenter, Mechanistic Study With a 24-Week Open-Label Follow-Up to Evaluate the Effect of Avandia on Bone in Postmenopausal Women With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 16 Oct 2012 Results assessing the effects of treatment on osteoclast activity presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research.
- 24 Mar 2012 Substudy assessing muscle mass and adiposity presented at the 2012 IOF World Congress on Osteoporosis and 11th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.
- 20 Sep 2011 Results assessing the effects of treatment on adiposity and muscle mass presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research.